vs

Side-by-side financial comparison of Alignment Healthcare, Inc. (ALHC) and First Solar (FSLR). Click either name above to swap in a different company.

First Solar is the larger business by last-quarter revenue ($1.7B vs $1.0B, roughly 1.7× Alignment Healthcare, Inc.). First Solar runs the higher net margin — 31.0% vs -1.1%, a 32.0% gap on every dollar of revenue. On growth, Alignment Healthcare, Inc. posted the faster year-over-year revenue change (44.4% vs 11.1%). First Solar produced more free cash flow last quarter ($1.1B vs $-55.4M). Over the past eight quarters, First Solar's revenue compounded faster (45.6% CAGR vs 26.9%).

Alignment Healthcare, Inc. is a U.S.-based healthcare provider offering Medicare Advantage plans for seniors. It adopts a value-based care model, partnering with local providers to deliver personalized coordinated medical services, prescription drug coverage and supplemental benefits to members across multiple U.S. states.

First Solar, Inc. is a publicly traded American manufacturer of solar panels. First Solar uses rigid thin-film modules for its solar panels, and produces CdTe panels using cadmium telluride (CdTe) as a semiconductor. The company was founded in 1990 by inventor Harold McMaster as Solar Cells, Inc. In 1999 it was purchased by True North Partners, LLC, which rebranded it as First Solar, Inc. It provides end-of-life panel recycling at each of its manufacturing facilities.

ALHC vs FSLR — Head-to-Head

Bigger by revenue
FSLR
FSLR
1.7× larger
FSLR
$1.7B
$1.0B
ALHC
Growing faster (revenue YoY)
ALHC
ALHC
+33.3% gap
ALHC
44.4%
11.1%
FSLR
Higher net margin
FSLR
FSLR
32.0% more per $
FSLR
31.0%
-1.1%
ALHC
More free cash flow
FSLR
FSLR
$1.1B more FCF
FSLR
$1.1B
$-55.4M
ALHC
Faster 2-yr revenue CAGR
FSLR
FSLR
Annualised
FSLR
45.6%
26.9%
ALHC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ALHC
ALHC
FSLR
FSLR
Revenue
$1.0B
$1.7B
Net Profit
$-11.0M
$520.9M
Gross Margin
39.5%
Operating Margin
-1.0%
32.6%
Net Margin
-1.1%
31.0%
Revenue YoY
44.4%
11.1%
Net Profit YoY
64.6%
32.5%
EPS (diluted)
$-0.04
$4.84

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALHC
ALHC
FSLR
FSLR
Q4 25
$1.0B
$1.7B
Q3 25
$993.7M
$1.6B
Q2 25
$1.0B
$1.1B
Q1 25
$926.9M
$844.6M
Q4 24
$701.2M
$1.5B
Q3 24
$692.4M
$887.7M
Q2 24
$681.3M
$1.0B
Q1 24
$628.6M
$794.1M
Net Profit
ALHC
ALHC
FSLR
FSLR
Q4 25
$-11.0M
$520.9M
Q3 25
$3.7M
$455.9M
Q2 25
$15.7M
$341.9M
Q1 25
$-9.1M
$209.5M
Q4 24
$-31.1M
$393.1M
Q3 24
$-26.4M
$313.0M
Q2 24
$-24.0M
$349.4M
Q1 24
$-46.5M
$236.6M
Gross Margin
ALHC
ALHC
FSLR
FSLR
Q4 25
39.5%
Q3 25
38.3%
Q2 25
45.6%
Q1 25
40.8%
Q4 24
37.5%
Q3 24
50.2%
Q2 24
49.4%
Q1 24
43.6%
Operating Margin
ALHC
ALHC
FSLR
FSLR
Q4 25
-1.0%
32.6%
Q3 25
0.8%
29.2%
Q2 25
2.2%
33.0%
Q1 25
-0.6%
26.2%
Q4 24
-3.2%
30.2%
Q3 24
-2.8%
36.3%
Q2 24
-2.7%
36.9%
Q1 24
-6.5%
30.6%
Net Margin
ALHC
ALHC
FSLR
FSLR
Q4 25
-1.1%
31.0%
Q3 25
0.4%
28.6%
Q2 25
1.5%
31.2%
Q1 25
-1.0%
24.8%
Q4 24
-4.4%
26.0%
Q3 24
-3.8%
35.3%
Q2 24
-3.5%
34.6%
Q1 24
-7.4%
29.8%
EPS (diluted)
ALHC
ALHC
FSLR
FSLR
Q4 25
$-0.04
$4.84
Q3 25
$0.02
$4.24
Q2 25
$0.07
$3.18
Q1 25
$-0.05
$1.95
Q4 24
$-0.15
$3.66
Q3 24
$-0.14
$2.91
Q2 24
$-0.13
$3.25
Q1 24
$-0.25
$2.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALHC
ALHC
FSLR
FSLR
Cash + ST InvestmentsLiquidity on hand
$604.2M
$2.8B
Total DebtLower is stronger
$323.2M
Stockholders' EquityBook value
$179.3M
$9.5B
Total Assets
$1.1B
$13.3B
Debt / EquityLower = less leverage
1.80×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALHC
ALHC
FSLR
FSLR
Q4 25
$604.2M
$2.8B
Q3 25
$644.1M
$2.0B
Q2 25
$503.8M
$1.1B
Q1 25
$479.5M
$837.6M
Q4 24
$470.6M
$1.6B
Q3 24
$381.0M
$1.0B
Q2 24
$363.7M
$1.7B
Q1 24
$301.7M
$1.7B
Total Debt
ALHC
ALHC
FSLR
FSLR
Q4 25
$323.2M
Q3 25
$322.7M
Q2 25
$322.3M
Q1 25
$321.9M
Q4 24
$321.4M
Q3 24
$212.0M
Q2 24
$211.7M
Q1 24
$162.0M
Stockholders' Equity
ALHC
ALHC
FSLR
FSLR
Q4 25
$179.3M
$9.5B
Q3 25
$161.9M
$9.0B
Q2 25
$141.0M
$8.5B
Q1 25
$108.1M
$8.2B
Q4 24
$99.9M
$8.0B
Q3 24
$114.5M
$7.6B
Q2 24
$123.7M
$7.3B
Q1 24
$130.9M
$6.9B
Total Assets
ALHC
ALHC
FSLR
FSLR
Q4 25
$1.1B
$13.3B
Q3 25
$1.1B
$13.5B
Q2 25
$1.0B
$12.9B
Q1 25
$895.6M
$12.1B
Q4 24
$782.1M
$12.1B
Q3 24
$692.3M
$11.4B
Q2 24
$716.3M
$11.0B
Q1 24
$633.2M
$10.8B
Debt / Equity
ALHC
ALHC
FSLR
FSLR
Q4 25
1.80×
Q3 25
1.99×
Q2 25
2.29×
Q1 25
2.98×
Q4 24
3.22×
Q3 24
1.85×
Q2 24
1.71×
Q1 24
1.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALHC
ALHC
FSLR
FSLR
Operating Cash FlowLast quarter
$-50.4M
$1.2B
Free Cash FlowOCF − Capex
$-55.4M
$1.1B
FCF MarginFCF / Revenue
-5.5%
63.6%
Capex IntensityCapex / Revenue
0.5%
10.2%
Cash ConversionOCF / Net Profit
2.38×
TTM Free Cash FlowTrailing 4 quarters
$113.1M
$1.2B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALHC
ALHC
FSLR
FSLR
Q4 25
$-50.4M
$1.2B
Q3 25
$144.6M
$1.3B
Q2 25
$29.1M
$149.6M
Q1 25
$16.6M
$-608.0M
Q4 24
$-8.7M
$811.0M
Q3 24
$26.2M
$-53.7M
Q2 24
$23.5M
$193.0M
Q1 24
$-6.2M
$267.7M
Free Cash Flow
ALHC
ALHC
FSLR
FSLR
Q4 25
$-55.4M
$1.1B
Q3 25
$139.1M
$1.1B
Q2 25
$21.1M
$-138.6M
Q1 25
$8.4M
$-813.9M
Q4 24
$-18.0M
$497.5M
Q3 24
$16.9M
$-487.7M
Q2 24
$11.8M
$-172.1M
Q1 24
$-17.4M
$-145.7M
FCF Margin
ALHC
ALHC
FSLR
FSLR
Q4 25
-5.5%
63.6%
Q3 25
14.0%
67.1%
Q2 25
2.1%
-12.6%
Q1 25
0.9%
-96.4%
Q4 24
-2.6%
32.9%
Q3 24
2.4%
-54.9%
Q2 24
1.7%
-17.0%
Q1 24
-2.8%
-18.4%
Capex Intensity
ALHC
ALHC
FSLR
FSLR
Q4 25
0.5%
10.2%
Q3 25
0.6%
12.8%
Q2 25
0.8%
26.3%
Q1 25
0.9%
24.4%
Q4 24
1.3%
20.7%
Q3 24
1.3%
48.9%
Q2 24
1.7%
36.1%
Q1 24
1.8%
52.1%
Cash Conversion
ALHC
ALHC
FSLR
FSLR
Q4 25
2.38×
Q3 25
38.77×
2.79×
Q2 25
1.86×
0.44×
Q1 25
-2.90×
Q4 24
2.06×
Q3 24
-0.17×
Q2 24
0.55×
Q1 24
1.13×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons